Guidance For Industry Investigator Responsibilities – Protecting The Rights, Safety, And Welfare Of Study Subjects
Contains Nonbinding Recommendations
TABLE OF CONTENTS
I. INTRODUCTION
II. OVERVIEW OF INVESTIGATOR RESPONSIBILITIES
III. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES
A. SUPERVISION OF THE CONDUCT OF A CLINICAL INVESTIGATION
1. What Is Appropriate Delegation of Study-Related Tasks?
2. What Is Adequate Training?
3. What Is Adequate Supervision of the Conduct of an Ongoing Clinical Trial?
4. What Are an Investigator’s Responsibilities for Oversight of Other Parties Involved in the Conduct of a Clinical Trial?
B. PROTECTING THE RIGHTS, SAFETY, AND WELFARE OF STUDY SUBJECTS.
1. Reasonable Medical Care Necessitated by Participation in a Clinical Trial.
2. Reasonable Access to Medical Care.
3. Protocol Violations that Present Unreasonable Risks.
ATTACHMENT A: COPY OF FORM 1572.
ATTACHMENT B: INVESTIGATOR RESPONSIBILITIES.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Additional copies are available from:
Office of Training and Communication
Division of Drug Information, HFD-240
Center for Drug Evaluation and Research
Food and Drug Administration
(Tel) 301-827-4573
http://www.fda.gov/cder/guidance/index.htm or
Office of Communication, Training and Manufacturers Assistance, HFM-40
Center for Biologics Evaluation and Research
Food and Drug Administration
http://www.fda.gov/cber/guidelines.htm (Tel) 800-835-4709 or 301-827-1800 or
Office of Health and Industry Programs
Division of Small Manufacturers, International, and Consumer Assistance, HFZ-220
Center for Devices and Radiological Health
Food and Drug Administration
Tel: 1-800-638-2041
http://www.fda.gov/cdrh U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Procedural
October 2009
Clinical Research News
Предстоящие клинические испытания
-
NCT02707042Идет наборЗаболевания: Normal Physiology, Здоровый
-
NCT03942887Идет наборЗаболевания: АНЦА-ассоциированный васкулит
-
NCT04847063Идет наборЗаболевания: Peritoneal Carcinomatosis, Перитонеальная мезотелиома, Рак яичников, Рак желудочно-кишечного тракта, Аппендикулярный рак
-
NCT00109174Идет наборЗаболевания: Нормальная физиология
-
NCT03767530Идет наборЗаболевания: Дисфункция мейбомиевых желез
-
NCT04004104Идет наборЗаболевания: Гепатопульмональный синдром
-
NCT03478878Идет наборЗаболевания: Reticular Pseudodrusen (RPD), Возрастная дегенерация желтого пятна
-
NCT04304820Идет наборЗаболевания: Тяжелая апластическая анемия
-
NCT04284787Идет наборЗаболевания: Acute Myeloid Leukemia, Острый миелоидный лейкоз, возникший в результате предшествующего миелодиспластического синдрома, Вторичный острый миелоидный лейкоз, Острый миелоидный лейкоз, связанный с терапией
-
NCT04181229Идет наборЗаболевания: Эпилепсия, резистентность к лекарствам
Recent CRA jobs
-
Regulatory Affairs Senior Associate - Generalist
-
Biostatistician All Levels - FSP
-
Biostatistician I - FSP
-
Principal Consultant - Regulatory Affairs Generalist
-
Consultant, Resource Management - Study Start Up - Homebased
-
Observational Specialist II
-
Manager, Client Services
-
Research Support Specialist 3- Rodent Behavioral and Physiological Phenotyping Technician
-
Team Leader Research (Team 1s) 1 1 1 1 1 1 1
-
Senior Principal Scientific Advisor